Carl Zeiss Meditec Past Earnings Performance
Past criteria checks 2/6
Carl Zeiss Meditec has been growing earnings at an average annual rate of 11.9%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9.8% per year. Carl Zeiss Meditec's return on equity is 8.8%, and it has net margins of 8.7%.
Key information
11.9%
Earnings growth rate
12.0%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 9.8% |
| Return on equity | 8.8% |
| Net Margin | 8.7% |
| Next Earnings Update | 12 Feb 2025 |
Recent past performance updates
Recent updates
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Dec 04
Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk
Nov 19Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital
Sep 19Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Sep 06Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?
Aug 23At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?
Aug 09Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Jul 11Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled
Jun 10Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing
May 26Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 11Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
May 09Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?
Mar 24Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Mar 11Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement
Feb 12Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jan 29What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Dec 08Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital
Nov 08Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Oct 24Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?
Sep 24Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?
Sep 08Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)
Jul 24We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)
Jun 19Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?
Jun 06Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?
May 22Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price
Apr 19Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet
Feb 26Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 10Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Jan 28Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Jan 12Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10
Dec 29Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10
Dec 14What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?
Nov 04Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)
Oct 18Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist
Sep 12Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly
Aug 25Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes
May 30Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?
Feb 27Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall
Feb 08Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
Dec 12Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger
Nov 06If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late
Sep 06Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)
Aug 08Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being
May 21Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems
May 18Revenue & Expenses Breakdown
How Carl Zeiss Meditec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,066 | 179 | 558 | 343 |
| 30 Jun 24 | 2,066 | 203 | 534 | 352 |
| 31 Mar 24 | 2,062 | 261 | 503 | 358 |
| 31 Dec 23 | 2,094 | 277 | 509 | 356 |
| 30 Sep 23 | 2,089 | 290 | 503 | 349 |
| 30 Jun 23 | 2,080 | 308 | 496 | 343 |
| 31 Mar 23 | 2,022 | 278 | 485 | 326 |
| 31 Dec 22 | 1,963 | 307 | 455 | 312 |
| 30 Sep 22 | 1,903 | 294 | 439 | 291 |
| 30 Jun 22 | 1,781 | 245 | 417 | 270 |
| 31 Mar 22 | 1,735 | 264 | 392 | 251 |
| 31 Dec 21 | 1,688 | 228 | 380 | 238 |
| 30 Sep 21 | 1,647 | 236 | 365 | 232 |
| 30 Jun 21 | 1,566 | 235 | 337 | 227 |
| 31 Mar 21 | 1,388 | 159 | 326 | 225 |
| 31 Dec 20 | 1,335 | 130 | 334 | 221 |
| 30 Sep 20 | 1,335 | 122 | 350 | 219 |
| 30 Jun 20 | 1,400 | 120 | 379 | 212 |
| 31 Mar 20 | 1,507 | 166 | 400 | 200 |
| 31 Dec 19 | 1,505 | 170 | 400 | 188 |
| 30 Sep 19 | 1,459 | 160 | 394 | 173 |
| 30 Jun 19 | 1,382 | 153 | 381 | 159 |
| 31 Mar 19 | 1,334 | 129 | 371 | 158 |
| 31 Dec 18 | 1,310 | 127 | 362 | 157 |
| 30 Sep 18 | 1,281 | 126 | 354 | 160 |
| 30 Jun 18 | 1,251 | 124 | 342 | 161 |
| 31 Mar 18 | 1,216 | 129 | 341 | 156 |
| 31 Dec 17 | 1,205 | 132 | 341 | 149 |
| 30 Sep 17 | 1,190 | 134 | 339 | 146 |
| 30 Jun 17 | 1,154 | 123 | 331 | 138 |
| 31 Mar 17 | 1,135 | 112 | 319 | 132 |
| 31 Dec 16 | 1,106 | 113 | 311 | 129 |
| 30 Sep 16 | 1,088 | 98 | 303 | 123 |
| 30 Jun 16 | 1,090 | 78 | 303 | 118 |
| 31 Mar 16 | 1,083 | 80 | 304 | 117 |
| 31 Dec 15 | 1,062 | 61 | 301 | 115 |
| 30 Sep 15 | 1,040 | 62 | 298 | 112 |
| 30 Jun 15 | 984 | 70 | 291 | 112 |
| 31 Mar 15 | 946 | 66 | 282 | 108 |
| 31 Dec 14 | 938 | 73 | 277 | 104 |
| 30 Sep 14 | 909 | 75 | 269 | 100 |
| 30 Jun 14 | 931 | 83 | 269 | 99 |
| 31 Mar 14 | 924 | 89 | 264 | 100 |
| 31 Dec 13 | 900 | 89 | 259 | 98 |
Quality Earnings: AFX has high quality earnings.
Growing Profit Margin: AFX's current net profit margins (8.7%) are lower than last year (13.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AFX's earnings have grown by 11.9% per year over the past 5 years.
Accelerating Growth: AFX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AFX had negative earnings growth (-38.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (10.1%).
Return on Equity
High ROE: AFX's Return on Equity (8.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 18:37 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Carl Zeiss Meditec AG is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pierre-Yves Gauthier | AlphaValue |
| Samuel England | Berenberg |
| Scott Bardo | Berenberg |